Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis

Peritoneal dissemination or metastasis is a relatively rare presentation of renal cell carcinoma. We report four cases of advanced renal cell carcinoma with peritoneal metastases treated with nivolumab. Three cases showed an objective response in the metastatic lesions including peritoneal sites. Af...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 65(2019), 10 vom: 07. Okt., Seite 413-419
Auteur principal: Hida, Takuya (Auteur)
Autres auteurs: Yamasaki, Toshinari, Banno, Haruka, Fuchigami, Yasushi, Hattahara, Kodai, Fujiwara, Maki, Suzuki, Ryosuke, Kita, Yuki, Yoshino, Takayuki, Goto, Takayuki, Sawada, Atsuro, Akamatsu, Shusuke, Saito, Ryoichi, Kobayashi, Takashi, Inoue, Takahiro, Ogawa, Osamu
Format: Article en ligne
Langue:Japanese
Publié: 2019
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Journal Article Nivolumab 31YO63LBSN
LEADER 01000caa a22002652c 4500
001 NLM303018410
003 DE-627
005 20250226060508.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||jpn c
024 7 |a 10.14989/ActaUrolJap_65_10_413  |2 doi 
028 5 2 |a pubmed25n1009.xml 
035 |a (DE-627)NLM303018410 
035 |a (NLM)31697887 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Hida, Takuya  |e verfasserin  |4 aut 
245 1 0 |a Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 19.11.2019 
500 |a Date Revised 08.01.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Peritoneal dissemination or metastasis is a relatively rare presentation of renal cell carcinoma. We report four cases of advanced renal cell carcinoma with peritoneal metastases treated with nivolumab. Three cases showed an objective response in the metastatic lesions including peritoneal sites. After nivolumab administration, the computed tomography scan showed a transient enlargement of peritoneal lesions in two cases, which could be considered as pseudoprogression. Temporal changes of neutrophil-tolymphocyte ratio, C-reactive protein, and eosinophil ratio during the clinical course reflected the treatment effect of nivolumab in these patients, indicating that these could be potential biomarkers of the response. To our knowledge, this is the first case series showing therapeutic activity of nivolumab against peritoneal metastases in patients with renal cell carcinoma 
650 4 |a Journal Article 
650 7 |a Nivolumab  |2 NLM 
650 7 |a 31YO63LBSN  |2 NLM 
700 1 |a Yamasaki, Toshinari  |e verfasserin  |4 aut 
700 1 |a Banno, Haruka  |e verfasserin  |4 aut 
700 1 |a Fuchigami, Yasushi  |e verfasserin  |4 aut 
700 1 |a Hattahara, Kodai  |e verfasserin  |4 aut 
700 1 |a Fujiwara, Maki  |e verfasserin  |4 aut 
700 1 |a Suzuki, Ryosuke  |e verfasserin  |4 aut 
700 1 |a Kita, Yuki  |e verfasserin  |4 aut 
700 1 |a Yoshino, Takayuki  |e verfasserin  |4 aut 
700 1 |a Goto, Takayuki  |e verfasserin  |4 aut 
700 1 |a Sawada, Atsuro  |e verfasserin  |4 aut 
700 1 |a Akamatsu, Shusuke  |e verfasserin  |4 aut 
700 1 |a Saito, Ryoichi  |e verfasserin  |4 aut 
700 1 |a Kobayashi, Takashi  |e verfasserin  |4 aut 
700 1 |a Inoue, Takahiro  |e verfasserin  |4 aut 
700 1 |a Ogawa, Osamu  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 65(2019), 10 vom: 07. Okt., Seite 413-419  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnas 
773 1 8 |g volume:65  |g year:2019  |g number:10  |g day:07  |g month:10  |g pages:413-419 
856 4 0 |u http://dx.doi.org/10.14989/ActaUrolJap_65_10_413  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 65  |j 2019  |e 10  |b 07  |c 10  |h 413-419